Friday, August 8, 2025

Diphtheria

Diphtheria: Causes, Symptoms, Treatment, and Prevention

~Introduction

Diphtheria is a potentially life-threatening bacterial infection that primarily affects the mucous membranes of the throat and nose but can also involve the skin and other organs. Once considered one of the most feared childhood diseases, it was responsible for countless deaths before the development of an effective vaccine in the 20th century. Today, diphtheria remains rare in countries with high vaccination coverage, but outbreaks still occur in regions where immunization rates have fallen or public health systems are weak.

Although modern medicine has drastically reduced diphtheria’s prevalence, the disease continues to be a global health concern because of its ability to spread quickly and cause severe complications, including heart failure, nerve damage, and respiratory obstruction. Understanding diphtheria’s history, pathology, clinical features, and prevention is key to ensuring it remains under control.

~History of Diphtheria

The name diphtheria is derived from the Greek word diphthera, meaning “leather,” referring to the tough gray membrane that forms in the throat of affected patients. Historical accounts of the disease date back to the 5th century BC, with Hippocrates describing symptoms consistent with diphtheria.

In the 19th century, major epidemics swept through Europe and North America, often killing thousands of children annually. The disease was so feared that it was nicknamed the strangling angel due to its suffocating membrane formation.

The turning point came in the late 1800s when Edwin Klebs and Friedrich Löffler identified the bacterium Corynebacterium diphtheriae. In 1890, Emil von Behring developed an antitoxin that could neutralize the diphtheria toxin, earning him the first Nobel Prize in Physiology or Medicine in 1901. The introduction of the diphtheria toxoid vaccine in the 1920s and widespread immunization programs in the mid-20th century led to a dramatic decline in cases.

~Causative Agent

Diphtheria is caused by Corynebacterium diphtheriae, a gram-positive, rod-shaped bacterium. It can be classified into four biotypes—gravis, mitis, intermedius, and belfanti—based on colony characteristics. The bacteria produce an exotoxin that is responsible for the severe symptoms and complications of the disease.

Only toxin-producing strains cause classical respiratory diphtheria. The toxin inhibits protein synthesis within host cells by inactivating elongation factor-2 (EF-2), leading to cell death and tissue necrosis.

~Transmission

Diphtheria spreads primarily through:

Respiratory droplets – from coughing, sneezing, or close contact with an infected person.
Direct contact – with skin lesions in cutaneous diphtheria.
Contaminated objects – rare, but possible if touched shortly after contamination.

The incubation period typically ranges from 2 to 5 days, but it can be as short as 1 day or as long as 10 days.

~Types of Diphtheria

Diphtheria can present in several forms:

Respiratory Diphtheria – affects the throat, tonsils, and nose; the most dangerous form.
Cutaneous Diphtheria – causes skin ulcers with a gray membrane, often in tropical climates.
Other Rare Forms – such as diphtheria of the conjunctiva, genitalia, or ear.

~Symptoms

Symptoms vary depending on the form of the disease.

Respiratory Diphtheria

Initial symptoms (mild to moderate):
- Sore throat
- Low-grade fever
- Malaise (feeling unwell)
- Swollen glands in the neck
Progressive symptoms:
- Thick gray or white pseudomembrane covering the tonsils and throat
- Difficulty breathing or swallowing
- Hoarseness
- Barking cough
Severe symptoms:
- Stridor (harsh, vibrating breathing sound)
- Cyanosis (bluish discoloration of skin due to lack of oxygen)

Cutaneous Diphtheria

Chronic skin ulcers with a dirty-gray membrane
Mild pain or discomfort
Secondary bacterial infections possible

~Complications

If untreated, diphtheria can cause serious complications due to toxin spread through the bloodstream.

Airway Obstruction – from the thick pseudomembrane in the throat.
Myocarditis – inflammation of the heart muscle, potentially causing arrhythmias or heart failure.
Neuropathy – nerve damage, leading to paralysis of the soft palate, eye muscles, or limbs.
Kidney Damage – due to toxin effects on renal tissue.
Death – mortality rates range from 5–10% in treated cases, and up to 20% or more in children under 5 and adults over 40.

~Diagnosis

Prompt diagnosis is crucial to prevent complications.

Clinical diagnosis is based on:

Presence of sore throat, fever, and pseudomembrane.
Enlarged, tender neck lymph nodes (“bull neck” appearance).

Laboratory confirmation:

Throat swab and culture to identify C. diphtheriae.
Toxin detection using Elek’s test or PCR.

~Treatment

Diphtheria treatment requires urgent medical attention.

1. Antitoxin Administration

The diphtheria antitoxin, derived from horse serum, neutralizes circulating toxin.
Must be given as soon as possible—delays increase risk of complications.
A skin test is done first to check for allergic reaction.

2. Antibiotics

Erythromycin or penicillin is typically used to kill the bacteria.
Reduces transmission and duration of infection.
Course usually lasts 14 days.

3. Supportive Care

Airway management in severe cases.
Bed rest and cardiac monitoring.
Treatment of complications such as heart failure or nerve damage.

~Prevention

Vaccination is the most effective preventive measure.

Diphtheria Vaccines

The diphtheria toxoid is included in combination vaccines:
- DTaP (Diphtheria, Tetanus, Pertussis) – for children.
- Tdap – booster for adolescents and adults.
- DT – for children who cannot receive pertussis component.
- Td – booster for adults.

Schedule:

Primary series: 3 doses in infancy (at 2, 4, 6 months).
Booster doses: at 15–18 months, 4–6 years, adolescence, and every 10 years thereafter.

Other Preventive Measures

Rapid isolation of infected individuals.
Contact tracing and prophylactic antibiotics for close contacts.
Maintaining high vaccination coverage in the community.

~Global Situation

Thanks to vaccines, diphtheria is rare in developed countries. However, the disease persists in parts of Africa, Asia, the Middle East, and Latin America, particularly in areas with poor immunization infrastructure.

According to the World Health Organization (WHO):

Around 8,000 cases were reported globally in 2022.
Outbreaks have occurred in conflict zones and refugee camps, where healthcare access is limited.

Challenges in Eradication

Vaccine hesitancy in some populations.
Conflict and migration disrupting immunization programs.
Underreporting in low-resource countries.
Emergence of antibiotic-resistant strains (though still uncommon).

~Case Studies

1. Former Soviet Union Epidemic (1990s)

After the collapse of the USSR, vaccination rates plummeted in several states. Between 1990 and 1998, over 150,000 cases and 5,000 deaths were reported—the largest diphtheria epidemic since the introduction of vaccines.

2. Yemen Outbreak (2017–2023)

Ongoing war severely disrupted vaccination programs. Thousands of suspected cases were reported, with children under 15 making up the majority.

~Public Health Strategies

Strengthening routine immunization services.
Ensuring adequate supply of antitoxin and antibiotics.
Educating communities about symptoms and prevention.
Rapid outbreak detection and response teams.

~Conclusion

Diphtheria, though now rare in many parts of the world, is not a disease of the past. It remains a serious health threat wherever vaccination coverage is low. The history of diphtheria teaches us that vigilance is essential—one lapse in immunization can allow the “strangling angel” to return with deadly force.

With strong public health systems, global cooperation, and continued commitment to vaccination, diphtheria can remain a controlled disease and possibly one day be eradicated. But until that day comes, awareness, prevention, and rapid treatment will remain our best defenses.

Health Lines